Skip to content

Clinical Evaluation of Two New Silicone Hydrogel Multifocal Products

Clinical Evaluation of Two New Silicone Hydrogel Multifocal Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00909792
Enrollment
259
Registered
2009-05-28
Start date
2009-05-31
Completion date
2009-06-30
Last updated
2012-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Brief summary

The objective of this trial is compare the visual performance, ratings, and preference of two multifocal, soft contact lenses.

Interventions

Silicone hydrogel, soft, multifocal contact lens

DEVICESenofilcon A

Silicone hydrogel, soft, multifocal contact lens

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be at least 35 years of age * Best-corrected distance visual acuity of at least 20/40 in each eye. * Spectacle add between +0.75D and +1.50D (inclusive). * Able to be fit in available study sphere powers (-1.00 to -5.00D) * Currently wearing soft contact lenses at least 5 days a week. * Other protocol inclusion/

Exclusion criteria

may apply.

Design outcomes

Primary

MeasureTime frameDescription
Corrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual AcuityAfter 1 week of wearTested while reading charts distant to the subject with both eyes together in normal lighting. This outcome is measured in logMAR units (logarithm of the minimum angle of resolution). A logMAR acuity of 0.0 equates to 20/20 Snellen acuity and is considered normal. Positive logMAR values indicate poorer vision and negative values denote better visual acuity.

Participant flow

Pre-assignment details

One participant was enrolled but not dispensed due to failing inclusion/exclusion criteria. This participant is included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.

Participants by arm

ArmCount
Overall
This reporting group includes all enrolled and dispensed subjects.
258
Total258

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1Did not meet inclusion criteria01
Period 2Biomicroscopy10
Period 2Lost to Follow-up01

Baseline characteristics

CharacteristicOverall
Age Continuous45.5 Years
STANDARD_DEVIATION 4.3
Sex: Female, Male
Female
222 Participants
Sex: Female, Male
Male
36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 2560 / 258
serious
Total, serious adverse events
0 / 2560 / 258

Outcome results

Primary

Corrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual Acuity

Tested while reading charts distant to the subject with both eyes together in normal lighting. This outcome is measured in logMAR units (logarithm of the minimum angle of resolution). A logMAR acuity of 0.0 equates to 20/20 Snellen acuity and is considered normal. Positive logMAR values indicate poorer vision and negative values denote better visual acuity.

Time frame: After 1 week of wear

Population: Per Protocol. Analysis excluded major protocol deviations as determined by masked review.

ArmMeasureValue (MEAN)Dispersion
Lotrafilcon B Multifocal Contact LensCorrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual Acuity-0.01 logMARStandard Deviation 0.06
Senofilcon A Multifocal Contact LensCorrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual Acuity0.01 logMARStandard Deviation 0.07

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026